Showing 15 posts of 294 posts found.


Boehringer buys cancer vaccine company AMAL Therapeutics for €325 million

July 16, 2019
Manufacturing and Production AMAL Therapeutics, Boehringer Ingelheim, Geneva, cancer vaccines, oncology

Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines. AMAL’s lead candidate, …


WHO leaves breakthrough cancer therapies off updated Essential Medicines List

July 10, 2019
Research and Development Cancer, EML, WHO, essential medicines list, oncology, pharma, world health organization

The World Health Organization (WHO) has updated its list of essential medicines to include 28 more drugs. The WHO’s Essential …

Boys in UK to be given HPV vaccine

July 9, 2019
Manufacturing and Production HPV, HPV vaccine, Vaccine, cervical cancer, oncology, pharma

Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. …


New urine test can diagnose and offer prognosis for prostate cancer

July 8, 2019
Sales and Marketing Cancer, oncology, pharma, prostate cancer, urine test

A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies. The test can also …

Scientists use cold virus to treat bladder cancer

July 5, 2019
Medical Communications, Research and Development CVA21, Cancer, bladder cancer, oncology, oncolytic, pharma, virus

A strain of the virus that causes the common cold has been found to potentially target, infect and kill cancer …

Cancer cost US more than $94 billion in lost earnings in 2015

July 4, 2019
Research and Development Cancer, economics, health, lost earnings, oncology, pharma

Cancer deaths cost the US economy $94.4 billion in lifetime earnings in 2015, according to figures from the American Cancer …

Pfizer’s Talzenna approved in Europe for HER2- advanced breast cancer with gBRCA1/2 mutations

June 24, 2019
Sales and Marketing Pfizer, breast cancer, oncology, pharma

Pfizer’s oral poly (ADP-ribose) polymerase (PARP) inhibitor Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker …


Dr Dietmar Berger returns to big pharma

May 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atara, R&D, Sanofi, oncology, pharma, research

Industry veteran Dr Dietmar Berger has joined Sanofi as the company’s new Global Head of Development. Dr Berger joins the …


GSK to reintroduce bonuses for sales reps

May 24, 2019
Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …


Japan’s health ministry warns of serious side effects of Lilly’s Verzenio

May 23, 2019
Business Services, Medical Communications Cancer, Eli Lilly, Verzenio, breast cancer, oncology, pharma

Japan’s Health Ministry has warned that Eli Lilly’s breast cancer therapy Verzenio could have serious side effects for patient’s lungs. …


MSD buys Peloton Therapeutics in deal worth $2.1 billion

May 22, 2019
Research and Development Cancer, MSD, acquisition, biotech, deal, oncology, pharma

MSD has agreed to acquire all outstanding shares in Peloton Therapeutics in a deal worth up to $2.1 billion. US …

Children wait six and half years longer than adults for new cancer drugs, study says

May 22, 2019
Research and Development Cancer, FDA, children, oncology, paediatrics, pharma

Children wait six and half years longer than adults to access new cancer drugs, according to a study from Dana-Farber/Boston …

ICR calls for faster access to innovative cancer drugs

April 25, 2019
Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing

The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …


Pfizer immune-oncology leader joins Aduro Biotech as new CMO

April 23, 2019
Manufacturing and Production Aduro Biotech, Cancer, Pfizer, immuno-oncology, immunotherapy, oncology

Pfizer’s vice president and head of immune-oncology clinical development has joined Aduro Biotech as the company’s new Chief Medical Officer, …

Bowel cancers adjust themselves to hide from immunotherapies

April 15, 2019
Sales and Marketing CEA, Cancer, bowel cancer, immunotherapy, oncology, tumour

Bowel cancers can avoid being caught by immunotherapy by ‘switching off’ a molecule on the surface of cells that is …

Latest content